Investor Presentaiton slide image

Investor Presentaiton

Extensive governmental response to tackle Covid-19 impact Economy Stimulus Program Covid-19 funds use in 2021 9!010 m SMEs support: Expansion of Affordable Loans "5-7-9%" program to help SMEs affected by the lockdown (UAH 83.5bn were issued since the start in February 2020) Provision of portfolio state guarantees for loans and partial compensation of loan principal. As of January 1, 2022, banks issued UAH 8.2bn of loans under portfolio state guarantees Moratorium on tax penalties, tax exemption and relief from tax debt during lockdown¹ One-off stimulating payments of c. US$ 300 per private entrepreneur in December 2020 and during 1H 2021 Population support: Expansion of "Affordable Mortgage at 7%” program to help low-income families (UAH 1.3bn of mortgages were issued in total as of January 2022) Unemployment and partial unemployment benefits, which includes raising the minimum support payment and providing immediate support to persons, who had just registered as unemployed One-off pension increase to low-income pensioners and monthly pension top-up for retirees aged 80+ years ♫ Transformation of the economy: Investments attraction: involvement of IFIs for the implementation of investment projects Innovation enhancement: digital transformation strategy, R&D stimulation, reform of scientific setup Infrastructure investments: reconstruction of roads, modernization of educational and medical institutions, reconstruction of cultural heritage sites Transportation sector reform: spin-off of Ukrzaliznytsia, reorganization of Seaport Authority, heavy investments into transportation infrastructure Sources CMU, Ministry of Finance, Parliament of Ukraine February 2022 UAHbn % of total Healthcare services procurement Vaccines procurement Social support of population Unemployment-related payments Total funds 25.0 56% 11.4 26% 3.5 8% 4.7 11% 44.7 100% Vaccine Vaccines procurement and rollout Administered Available Received (30.01.2022) 2022-23 (30.01.2022) 1st dose 2nd dose Pfizer 50.0m 23.2m 6.7m 6.7m Sinovac 6.5m 10.4m 4.9m 4.7m Moderna 0.0m 5.1m 1.5m 1.4m AstraZeneca 0.0m 5.3m 2.1m 1.9m Covax³ 10.0m n/a n/a n/a Total 66.5m 44.0m 15.3m 14.6m Note 1 Effective during April-May 2020, January 2021 and April 2021 Note 2 Disbursement of funds compared to budget plan Note 3 10m vaccines under Covax program, while specific vaccines are not identified 4
View entire presentation